BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Cerilliant
Cipla
Covington
AstraZeneca
Teva
McKesson
UBS
Merck
Dow

Generated: January 23, 2018

DrugPatentWatch Database Preview

Alprostadil - Generic Drug Details

« Back to Dashboard

What are the generic sources for alprostadil and what is the scope of alprostadil freedom to operate?

Alprostadil
is the generic ingredient in six branded drugs marketed by Teva Pharms Usa, West-ward Pharms Int, Pfizer, Pharmacia And Upjohn, Auxilium Pharms Llc, and Mylan Speciality Lp, and is included in eight NDAs. Additional information is available in the individual branded drug profile pages.

There are seven drug master file entries for alprostadil. Five suppliers are listed for this compound.
Medical Subject Heading (MeSH) Categories for alprostadil

US Patents and Regulatory Information for alprostadil

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Speciality Lp MUSE alprostadil SUPPOSITORY;URETHRAL 020700-003 Nov 19, 1996 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pfizer CAVERJECT alprostadil INJECTABLE;INJECTION 020755-002 Oct 1, 1997 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
West-ward Pharms Int ALPROSTADIL alprostadil INJECTABLE;INJECTION 074815-001 Jan 20, 1998 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pharmacia And Upjohn CAVERJECT alprostadil INJECTABLE;INJECTION 020379-003 Jun 27, 1996 RX Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pharmacia And Upjohn CAVERJECT alprostadil INJECTABLE;INJECTION 020379-001 Jul 6, 1995 AP RX Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan Speciality Lp MUSE alprostadil SUPPOSITORY;URETHRAL 020700-002 Nov 19, 1996 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Auxilium Pharms Llc EDEX alprostadil INJECTABLE;INJECTION 020649-005 Jul 30, 1998 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Auxilium Pharms Llc EDEX alprostadil INJECTABLE;INJECTION 020649-007 Jul 30, 1998 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Auxilium Pharms Llc EDEX alprostadil INJECTABLE;INJECTION 020649-004 Jun 12, 1997 AP RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pfizer CAVERJECT alprostadil INJECTABLE;INJECTION 020755-003 Oct 1, 1997 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for alprostadil

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Mylan Speciality Lp MUSE alprostadil SUPPOSITORY;URETHRAL 020700-002 Nov 19, 1996 ➤ Subscribe ➤ Subscribe
Pharmacia And Upjohn CAVERJECT IMPULSE alprostadil INJECTABLE;INJECTION 021212-002 Jun 11, 2002 ➤ Subscribe ➤ Subscribe
Mylan Speciality Lp MUSE alprostadil SUPPOSITORY;URETHRAL 020700-001 Nov 19, 1996 ➤ Subscribe ➤ Subscribe
Pharmacia And Upjohn CAVERJECT IMPULSE alprostadil INJECTABLE;INJECTION 021212-002 Jun 11, 2002 ➤ Subscribe ➤ Subscribe
Pharmacia And Upjohn CAVERJECT alprostadil INJECTABLE;INJECTION 020379-003 Jun 27, 1996 ➤ Subscribe ➤ Subscribe
Mylan Speciality Lp MUSE alprostadil SUPPOSITORY;URETHRAL 020700-002 Nov 19, 1996 ➤ Subscribe ➤ Subscribe
Mylan Speciality Lp MUSE alprostadil SUPPOSITORY;URETHRAL 020700-003 Nov 19, 1996 ➤ Subscribe ➤ Subscribe
Mylan Speciality Lp MUSE alprostadil SUPPOSITORY;URETHRAL 020700-004 Nov 19, 1996 ➤ Subscribe ➤ Subscribe
Mylan Speciality Lp MUSE alprostadil SUPPOSITORY;URETHRAL 020700-001 Nov 19, 1996 ➤ Subscribe ➤ Subscribe
Mylan Speciality Lp MUSE alprostadil SUPPOSITORY;URETHRAL 020700-002 Nov 19, 1996 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Cipla
Fuji
Johnson and Johnson
Julphar
Covington
Argus Health
Harvard Business School
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot